Cita APA

A, F., M, S., A, G., Buxo, E., Vera, R., Adeva, J., . . . Carmona-Bayonas, A. (2018). Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: The ANICE-PaC study.

Citación estilo Chicago

A, Fernández, et al. Prognostic Factors for Survival With Nab-paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer in Real-life Practice: The ANICE-PaC Study. 2018.

Cita MLA

A, Fernández, et al. Prognostic Factors for Survival With Nab-paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer in Real-life Practice: The ANICE-PaC Study. 2018.